Long-term safety and efficacy of two different antimuscarinics, imidafenacine and solifenacin, for treatment of overactive bladder: A prospective randomized controlled study.
Long-term safety and efficacy of two different antimuscarinics, imidafenacine and solifenacin, for treatment of overactive bladder: A prospective randomized controlled study.
复制标题
两种不同的抗毒蕈碱药物——咪达芬那辛和索利那新治疗膀胱过度活动症的长期安全性和有效性：一项前瞻性随机对照研究。
作者：
Satoru Kanto;Kazumitsu Yamasaki;Teruaki Iwamoto;Yuji Tsuji;Atsushi Fukuzaki;保富宗城;Yokoyama T
